Adaptyv Biosystems Sàrl

Next-generation protein engineering

Proteins are the most advanced nanotechnology we know of. Engineered proteins such as new antibodies, enzymes, gene therapy vectors and motor proteins will be at the core of the biorevolution and change how we think about curing diseases, manufacturing products and designing new materials.
At Adaptyv Bio we're building a next-generation protein foundry. We combine advanced robotics, microfluidics and synthetic biology techniques to create fully automated protein engineering workcells that allow users to synthesize and test any protein they design.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

No milestones

No Jobs

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Website

EPFL Spin-Off

Website

Adaptyv Biosystems Sàrl

Next-generation protein engineering

Headquarter:
Epalinges

Foundation Date:
November 2021

Technology:

  • Biotech

Sectors:

  • Antibodies
  • Biotech
  • Drug development platforms
  • Drug discovery
  • Machine Learning / AI
  • Protein drugs

Support received

  • Support venturekick